Our strategy Our current strategic period started in 2021, setting out our vision and goals to achieve testing for healthy and safe lives.
ACT-Accelerator We co-convene the diagnostics pillar of this global collaboration to ensure access to COVID-19 tests for everyone, everywhere.
G20 in India We are highlighting the importance of diagnostics in ensuring that the G20 health priorities are achieved.
100 Days Mission A plan for the world to be able to respond to and extinguish the global threat of the next Disease X within 100 days of WHO declaring a major outbreak or pandemic.
Diagnostics & IP Find out how intellectual property rights are protected in the diagnostics industry.
Press release FIND welcomes adoption of historic World Health Assembly Resolution on diagnostics as the organization enters its 20th anniversary year
DxConnect Tools and resources provided under the DxConnect umbrella contain information managed and collated – but not owned – by FIND, as a service to the diagnostics community.
Data for decisions Diagnostics provide critical information for healthcare professionals, decision-makers, and people living with diseases and health conditions.
The diagnostic journey From R&D to implementation, the diagnostic value chain can be thought of as a journey of interconnected steps, or a "virtuous cycle".
Diagnostics Commission The Lancet Commission on diagnostics was published in 2021, putting forward recommendations to accelerate and transform access to diagnostics globally.
Finding silent TB infections to help End TB Come with B. Narayana, as he travels through Mahabubnagar, meeting families whose households have been affected by TB and offering tests and treatment for silent TB infection.
Stopping TB before it starts to avoid stigma Meet Lalitha - she and her daughters were diagnosed with silent TB infection and opted to take preventive treatment to stop them from getting active TB and avoid the stigma of the disease.
Joint Effort for Elimination of TB (JEET) Project JEET was originally set up to strengthen TB services and seamlessly extend quality TB care to patients in the private sector. JEET 2.0 is focused on testing and treating silent TB infections.
G20 presidency of India: leveraging digital health and diagnostics to drive universal heatlh coverage
What does it take to achieve microelimination of hepatitis C among incarcerated individuals in Haryana, India?
Press release The Global Fund grants US$37 million to FIND to advance tuberculosis prevention and control in India
Press release FIND and IHF partner with MCGM to expand access to COVID-19 and tuberculosis dual testing in Mumbai
